OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
New Insights in the Era of Clinical Biomarkers as Potential Predictors of Systemic Therapy-Induced Cardiotoxicity in Women with Breast Cancer: A Systematic Review
Alexia Alexandraki, Elisavet Papageorgiou, Marina Zacharia, et al.
Cancers (2023) Vol. 15, Iss. 13, pp. 3290-3290
Open Access | Times Cited: 8
Alexia Alexandraki, Elisavet Papageorgiou, Marina Zacharia, et al.
Cancers (2023) Vol. 15, Iss. 13, pp. 3290-3290
Open Access | Times Cited: 8
Showing 8 citing articles:
Cardiovascular Biomarkers in Cardio-Oncology: Antineoplastic Drug Cardiotoxicity and Beyond
Umberto Attanasio, Elena Di Sarro, Lucia Tricarico, et al.
Biomolecules (2024) Vol. 14, Iss. 2, pp. 199-199
Open Access | Times Cited: 6
Umberto Attanasio, Elena Di Sarro, Lucia Tricarico, et al.
Biomolecules (2024) Vol. 14, Iss. 2, pp. 199-199
Open Access | Times Cited: 6
Anti-apoptotic and antioxidant mechanisms may underlie the abrogative potential of Ocimum gratissimum Linn. Leaf extract and fractions against trastuzumab-induced cardiotoxicity in Wistar rats
Olufunke E. Olorundare, Adejuwon Adewale Adeneye, Akinyele Olubiyi Akinsola, et al.
Toxicology Reports (2024) Vol. 12, pp. 200-214
Open Access | Times Cited: 5
Olufunke E. Olorundare, Adejuwon Adewale Adeneye, Akinyele Olubiyi Akinsola, et al.
Toxicology Reports (2024) Vol. 12, pp. 200-214
Open Access | Times Cited: 5
Review of the clinical status of cardiotoxicity of HER-2 positive breast cancer targeted therapeutic drugs
Xiang Zhang, Yulian Yin, Qingliang Yu, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access
Xiang Zhang, Yulian Yin, Qingliang Yu, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access
Anthracycline-induced cardiotoxicity: emerging mechanisms and therapies
Guanjing Ling, Fei Ge, Weili Li, et al.
Medicine Plus (2025), pp. 100074-100074
Open Access
Guanjing Ling, Fei Ge, Weili Li, et al.
Medicine Plus (2025), pp. 100074-100074
Open Access
Chemotherapy-related cardiotoxicity and its symptoms in patients with breast cancer: a scoping review
Hyunjoo Kim, Bomi Hong, Sanghee Kim, et al.
Systematic Reviews (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Hyunjoo Kim, Bomi Hong, Sanghee Kim, et al.
Systematic Reviews (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 2
HER2/neu 655 polymorphism, trastuzumab-induced cardiotoxicity, and survival in HER2-positive breast cancer patients
Isabel Blancas, Marina Linares-Rodríguez, Celia Martín‐Bravo, et al.
Clinical & Translational Oncology (2024) Vol. 26, Iss. 10, pp. 2531-2540
Open Access | Times Cited: 1
Isabel Blancas, Marina Linares-Rodríguez, Celia Martín‐Bravo, et al.
Clinical & Translational Oncology (2024) Vol. 26, Iss. 10, pp. 2531-2540
Open Access | Times Cited: 1
Serum Biomarkers to Dynamically Predict the Risk of Cardiovascular Events in Patients under Oncologic Therapy. A Multicenter Observational Study
Nicoletta Provinciali, Marco Piccininno, Giacomo Siri, et al.
Reviews in Cardiovascular Medicine (2024) Vol. 25, Iss. 7
Open Access
Nicoletta Provinciali, Marco Piccininno, Giacomo Siri, et al.
Reviews in Cardiovascular Medicine (2024) Vol. 25, Iss. 7
Open Access
The Impact of Chemotherapy on Arterial Stiffness and Ventricular–Arterial Coupling in Women with Breast Cancer
Nikolaos P.E. Kadoglou, Alexandriani Dimopoulou, Irene Tsappa, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 9, pp. 1115-1115
Open Access
Nikolaos P.E. Kadoglou, Alexandriani Dimopoulou, Irene Tsappa, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 9, pp. 1115-1115
Open Access
